Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists.
Chloroquine, quanine, procaine, quinidine, clomipramine, theophylline, and caffeine have been shown to be strong prostaglandin antagonists and weak agonists. The antagonist effect is clearly demonstrable at concentrations reached in human plasma when the drugs are used therapeutically. This suggests that prostaglandins are important in several situations in which their role has hitherto been unsuspected. New approaches to the development of prostaglandin antagonists and new uses for established drugs are indicated. In a preliminary study chloroquine has been successfully used to close patent ductus arteriosus in three infants.
D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology* / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D002738:Chloroquine / Q000494:pharmacology*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D006801:Humans; D007223:Infant; D011343:Procaine / Q000494:pharmacology* / Q000627:therapeutic use; D011448:Prostaglandin Antagonists; D011802:Quinidine / Q000494:pharmacology* / Q000627:therapeutic use; D011803:Quinine / Q000494:pharmacology*; D014970:Xanthines / Q000494:pharmacology* / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D000962:Antimalarials; D011448:Prostaglandin Antagonists; D014970:Xanthines; D011343:Procaine; D002738:Chloroquine; D011803:Quinine; D011802:Quinidine